The House of Representatives last night approved 25 bills to combat the opioid crisis, including four supported by the AHA. The AHA-supported bills would provide resources for hospitals to develop protocols on discharging patients who have presented with an opioid overdose (H.R. 5176); establish a demonstration program to test alternative pain management protocols to limit opioid use in hospital emergency departments (H.R. 5197); direct the Centers for Medicare & Medicaid Services to evaluate coverage of abuse-deterrent opioids in Medicare plans (H.R. 5582); and include opioid use and pain management resources in the “Medicare & You” handbook (H.R. 5685). Next week, the House is expected to consider additional AHA-supported bills, including bills to improve information sharing among providers with regard to substance use disorder treatment by aligning 42 CFR Part 2 regulations with the Health Insurance Portability and Accountability Act; and allow states to receive federal matching funds for up to 30 days per year for services provided to adult Medicaid beneficiaries with an opioid use disorder in an Institution for Mental Disease. 
 

Related News Articles

Headline
The AHA July 15 commented to Sens. Sheldon Whitehouse, D-R.I., and Bill Cassidy, R-La., responding to a request for information based on the Pay PCPs Act,…
Headline
The House Appropriations Committee July 10 voted 31-25 to approve legislation that would provide $185.8 billion in funding for the departments of Labor, Health…
Headline
The House Energy and Commerce Committee June 12 passed AHA-supported legislation during a markup of bills that passed the Health Subcommittee in May. The…
Headline
The AHA praised House and Senate leaders in letters June 12 for reintroducing the Improving Seniors’ Timely Access to Care Act, bipartisan legislation that…
Headline
The AHA June 7 submitted comments on a discussion draft of the Drug Shortage Prevention and Mitigation Act, bipartisan legislation proposing to provide…
Headline
The House Energy and Commerce Oversight and Investigations subcommittee June 4 hosted a hearing to discuss oversight of the 340B Drug Pricing Program. AHA sent…